Trial intelligence / Profile preview

Prospective study of Asplarg-Lyophilized powder in male oligospermia and asthenospermia

ChiCTR2100047698Phase 4Completed

Sponsor
West China Second University Hospital
Start
Dec 2017
Countries
1
01

Overview

Phase 4, randomised trial of Asplarg in male infertility (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Semen parameters and Serum sex hormone levels. Started Dec 2017; status: completed.

02

Drugs

Asplarg
03

Conditions

male infertility

Beyond the preview

Go deeper on ChiCTR2100047698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call